Toray Industries: A Long-Term Owner's Study

The Business, the Industry, and the Moat

How exactly does this company make money

Toray is in essence a B2B diversified materials company. As of the end of March 2026 it had 308 group companies and 46,294 employees, with operations spanning fibers, performance products, carbon-fiber composites, environment and engineering, water treatment, and pharmaceuticals and medical devices. FY2026 revenue was JPY 2.585 trillion; by operating revenue, fibers were about JPY 1.051 trillion, performance products about JPY 894.4 billion, carbon fiber about JPY 300.1 billion, environment and engineering about JPY 266.9 billion, and life sciences about JPY 52.4 billion. In other words, it is not a bet on a single product but on a "materials-technology platform plus a global manufacturing and sales network."

If you break it down further, the economics of the five main earnings engines are not uniform. Fibers and textiles are the largest but more mature base business; under performance products sit resins, chemicals, films, and electronic and information materials, of which some electronic materials and functional films carry more technical content. The carbon-fiber business has high technical barriers, but its capital returns have not been high over the past few years; within environment and engineering, the highest-quality part is really water-treatment membranes; life sciences is small and has had weak profitability in recent years. In FY2025 the segments' revenue shares were roughly: fibers 39%, performance products 37%, carbon fiber 12%, environment and engineering 9%, and life sciences 2%; core operating margins in the same period were about 6.3%, 6.4%, 7.5%, 11.0%, and negative, respectively.

Who are the customers? Public materials show that Toray's end-market exposure spans apparel, automotive, aerospace, semiconductors, seawater desalination, wastewater reuse, medical devices, and more. Carbon fiber, for example, serves aviation, automotive, energy, sports, electronics, and medical customers; water treatment serves desalination projects, wastewater reuse, and semiconductor ultrapure water; the fiber business covers both apparel and applications such as airbags, industrial materials, and artificial suede. Put differently, the company is not obviously dependent on a single end market, but each segment carries its own cyclicality and supply-demand swings.

Is the revenue recurring, stable, and predictable? The answer is partly recurring, but not smooth enough at the group level. Water-treatment membranes have clear replacement demand; in IR briefings the company directly notes that RO-membrane replacement demand will grow as the installed base accumulates, and that wastewater-reuse demand is expected to expand at about 6%–7% a year. That kind of revenue is closer to a "install-plus-replace" semi-recurring type. By contrast, fibers, resins, base films, and general industrial uses within carbon fiber are more exposed to the cycle, competition, and pricing. The group as a whole therefore combines "the recurrence of good businesses" with "the cyclicality of the materials industry," and the result is that individual segments look fine while the consolidated statements are not predictable enough.

On cost structure, Toray follows a classic heavy-asset manufacturing model. FY2026 operating cash flow was JPY 211.8 billion, depreciation and amortization JPY 131.6 billion, and capex about JPY 148.7 billion; in its new mid-term plan the company further proposes cumulative equipment investment of JPY 400–500 billion and R&D spending of JPY 250 billion over the three years 2026–2028. This business cannot do without continuous line investment, equipment renewal, process development, and maintenance of a global manufacturing network. It is not a "light-capital software" model but a capital-intensive one built on "materials technology plus manufacturing execution."

If the stock market closed for five years, my stance on this business would be: I would be willing to own several of its segments, but not necessarily the whole group at the current price. Water-treatment membranes, parts of semiconductor and electronic materials, and aerospace carbon fiber are worth owning for the long run; the problem is that you are buying the entire company, and the entire company still carries mature fibers, a weak life-sciences arm, several businesses under structural reform, and meaningful capex needs. This is not "I don't understand it," but "once you understand it, you find it is not simple enough." On that basis I rate business understandability 3/5.

The Industry and Competitive Landscape

Toray is not in a single industry but in a combination of multiple materials sub-industries. By life-cycle stage: fibers, general-purpose resins, and some base films are closer to mature or even cyclical; water-treatment membranes, high-function films tied to data centers and semiconductors, parts of electronic materials, and aerospace and high-pressure-vessel carbon fiber still have structural growth room. Management all but spells out this reality in the mid-term plan: the target for performance products is to raise ROIC from the 7% outlook for 2025 to 10% by 2028, carbon fiber from 2% to 6%, and water treatment and medical from 9% to 14%. This shows the company itself acknowledges that what is truly attractive is the high-value-added segments, not the group average.

Long-term demand overall is not fragile, but it is highly differentiated. Water treatment is driven by water scarcity and desalination and reuse demand, and in the relevant business briefings Toray cites desalination replacement demand and 6%–7% annual growth for wastewater reuse; semiconductor-related ultrapure water and functional materials are also propelled by AI, data centers, and advanced manufacturing; aerospace improves with the recovery of commercial aircraft and growing space and defense demand. By contrast, demand for fibers, automotive materials, and general-purpose resins is more exposed to the economic cycle, overseas competition, and price wars.

Is the industry easily disrupted by technology, regulation, or shifting consumer habits? The answer is locally easy, globally a steady evolution. The company itself explicitly lists, among its risk factors, changes in demand and market conditions, material substitution, new entrants, tariff and tax changes, climate and carbon pricing, and supply-chain disruption as potential blows to results. A large part of why FY2026 operating profit is markedly lower than business profit comes from non-recurring items such as battery-separator equipment impairment and a warehouse fire; FY2025, in turn, had carbon-fiber wind-power-related impairment. For a materials company, technological substitution is not an abstract risk but a reality that has already happened.

It is hard to name a single main competitor, because different segments face different rivals. Among comparable Japanese diversified-materials and chemical companies, Kuraray, Asahi Kasei, Teijin, and Mitsubishi Chemical Group can all serve as valuation or operating references; in carbon fiber, the global field involves more specialized materials competition; in water treatment, the rivals are global membrane suppliers. For investment comparison, I would rather use Kuraray as the "strongest reference," because it is more focused on specialty materials than Toray and its business structure is easier to analyze.

Toray's position in the industry is a strong player in several segments plus a complex group whose overall return is not high enough. In its annual report the company says its carbon-fiber business has established a solid position in the global market; its water-treatment membrane business claims a globally leading share in RO membranes for seawater desalination and ultrapure water, and that it is the only maker able to independently develop the full range of RO/NF/UF/MF membrane products. At the same time, although the fiber business is large in scale, its core operating margin is only mid-single-digit and it is affected by overseas competition and an incomplete automotive recovery. My judgment, then, is that Toray is more like "some good businesses inside ordinary industries" than a whole company standing in good industries. Industry attractiveness 3/5.

Moat Analysis

Note: this table judges the "group level," not the single strongest segment.

To be more specific, the places where Toray truly resembles a moat lie not in the whole group but in high-reliability certified materials, membrane-system solutions, process know-how, and global delivery capability. The water-treatment business has the strongest articulation: the company claims a globally leading share in RO membranes for desalination and ultrapure water, with advantages built on in-house development of the full membrane range and a globally integrated sales, technical, and R&D network; carbon fiber emphasizes four-pole production, long-term reliability, high-performance grades, and intermediate-materials capability; the fiber business's advantage lies more in the global supply chain and vertical integration than in strong pricing power.

Is this moat widening, stable, or narrowing? My inference is that the group-average moat is broadly stable, but internally "the strong get stronger and the weak get weaker." Water treatment looks more like an expanding moat in both demand and share; management has even disclosed that the business's revenue CAGR over the past decade was about 10% with double-digit ROIC. Electronic and information materials can maintain high share in specific applications through technology and customer collaboration; but low-value-added fibers, some general-purpose membranes, and separator-type assets are more easily compressed by competition and capacity cycles. In other words, Toray's moat is not disappearing but "concentrating." Moat strength 3/5.

Can it raise prices in an inflationary environment? The answer is locally yes, limited overall. The annual report shows the company explicitly pursues strategic pricing based on customer-value analysis in functional films and electronic materials, and reflects added value into price in high-value-added applications; but the risk factors likewise note that changes in conditions, new entrants, and price declines can hit demand and profit. Toray is not without pricing power, but it exists only in high-tech, high-reliability, strongly synergistic segment products, and cannot cover the entire group.

Can it stay profitable in a downturn? Historically, it survives, but the quality of its profitability clearly steps down. In FY2024, at the profit trough, the company still had positive operating cash flow and positive net income, but ROE was only 1.3% and ROIC 2.8%; in FY2026, after several impairments, ROE was still only 4.5%. This shows resilience, but not the kind of excellent-business trait that delivers "high returns even into a headwind."

Management and Capital Allocation

Is management trustworthy

On governance structure, Toray is not a founder-with-high-ownership company. As of April 1, 2026, the board comprised 10 directors, 4 of them outside directors; the major shareholders are mainly Japan trust banks, insurers, and financial institutions, not individual managers. Attendance at the board and governance committees is generally high; disclosed records show that the main directors and outside directors were almost all at full or near-full attendance in fiscal 2024. In other words, the governance structure looks like a typical large-cap Japanese manufacturer rather than a family or founder model in which the boss and shareholders are tightly bound.

On communication, I give management "basically honest, but not especially outstanding." On the positive side, in the long-term management policy released in March 2026 the company explicitly admits that the revenue and profit targets of AP-G 2025 were not met, citing reasons including tariff impacts and a lag in scaling growth businesses; that deserves more credit than only telling the good news. On the other hand, the past few years still saw asset impairments in wind-power-related carbon fiber and Korean battery separators, showing that management cannot always make accurate enough demand judgments before committing capital.

Is management's ownership highly aligned with shareholders? Public materials do not show managers holding huge stakes the way an American founder-CEO might. The more realistic alignment of interests comes from stock-based compensation, institutional-shareholder discipline, and a returns orientation. The company disclosed the scale of stock-option expense in its securities report, and from 2025 began advancing compensation-system reform, replacing the old stock-option scheme with a restricted-stock approach; that helps with long-term orientation but is not equivalent to "large self-funded ownership." The most one can give here is "improving governance, ordinary ownership alignment."

Is capital allocation rational

Over the past two years, the most commendable capital-allocation move at Toray has been cutting strategic cross-shareholdings and using the proceeds for buybacks. In 2024 the company proposed to cut strategic shareholdings by 50%, about JPY 100 billion, over the three years 2024–2026, and to use the full sale proceeds for its own share purchases; by the end of March 2025, management had disclosed selling JPY 109.8 billion of strategic shareholdings in fiscal 2024, meeting the target two years early, with the strategic-shareholding balance falling to 5.4% of total capital. In November 2025, the company further decided to buy back up to JPY 50 billion of shares and to cancel 127 million shares.

This capital-allocation move has already concretely improved per-share metrics. FY2026 net income attributable to owners grew only 2.1% year on year, but basic EPS rose from JPY 48.93 to JPY 52.96, an increase of about 8.2%, clearly above net-income growth, precisely because of the shrinking share count. Shares outstanding at period-end fell from 1,631,481,403 to 1,504,481,403, and treasury shares from 67,768,474 to 48,344,096, showing that buybacks and cancellations will have a lasting effect on per-share value. On the act itself, swapping very low-efficiency assets for cancelled shares, I think it is the right call.

But capital allocation cannot be judged on the past two years alone. Over a longer horizon the historical record is not excellent: the company has separately recognized large impairments on carbon-fiber wind-power assets and Korean battery-separator assets, and FY2026 still carried JPY 33.796 billion of impairment losses, of which Korean battery separators took a fixed-asset impairment of JPY 25.072 billion as the EV market slumped. In other words, management is indeed course-correcting today, but the reason course correction is needed is precisely that the returns on some earlier investments fell short. As a long-term shareholder, one should credit "improving rationality" rather than "already-proven excellent rationality."

On shareholder-return policy, the new mid-term plan proposes a DOE of 3% or more by 2028, with progressive dividends and flexible buybacks. FY2026 actual full-year dividends were JPY 20, and the FY2027 forecast is JPY 26, with the interim-dividend forecast including a JPY 3 commemorative dividend. The direction is constructive, but I would offer one caution: for a capital-intensive company like Toray, dividends and buybacks must ultimately be built on higher-quality operating cash flow, and cannot rely on asset disposals over the long run.

On balance, management and capital allocation 3/5. The reasoning is simple: it is more right now than in the past, but the past was not outstanding; the actions of the past two years deserve recognition, but they have not yet run long enough to erase the historical record of low returns.

Financial Quality and Owner Earnings

Key Financial Quality

The table below organizes the company's key financial metrics for FY2021–FY2026. FY2021–FY2025 come from the company's IR financial-data download files, and FY2026 from the earnings summary dated May 13, 2026.

Note: "Adjusted FCF" in the table approximates operating cash flow minus capex and excludes gains on disposal of investment securities; units are billions of yen.

By trend, revenue recovered notably over the five years 2021–2026, but margins were not stable. The FY2025 operating margin briefly recovered to about 5.0%, then fell back to 3.8% in FY2026; ROIC improved from 2.7% in FY2023 to 4.7% in FY2026, but still falls short of the high-single-digit or even double-digit levels common at a truly excellent industrial company. This shows that Toray's operations are healing, but are far from a "high-quality compounding" state.

Operating cash flow is positive overall, an important plus for financial quality. FY2026 operating cash flow was JPY 211.763 billion, again positive; the change in receivables was an outflow of JPY 18.613 billion, inventory released a small JPY 2.980 billion, and the change in payables was an outflow of JPY 1.297 billion, showing that working capital was a mild drag on cash flow in 2026 rather than an unusual flattering item. Profits are not "pure accounting illusion," but working capital did not deliver an especially pretty cash dividend either.

On leverage, the balance sheet is broadly sound but not especially light. At FY2026 period-end, total assets were JPY 3.477 trillion, equity attributable to owners JPY 1.800 trillion, equity ratio 51.8%, interest-bearing debt JPY 905.559 billion, and cash and equivalents JPY 265.295 billion, with D/E of 0.50. Estimating EBITDA roughly as operating profit plus depreciation, net debt to EBITDA is about 2.8x, EBIT to net financial expense coverage about 11x, and EBITDA to interest-payment coverage about 13x, within a tolerable range rather than a high-risk financial structure.

Capex intensity is the point that must be emphasized here. FY2026 capex was about JPY 148.7 billion, close to depreciation and amortization of JPY 131.6 billion; and the mid-term plan still prepares to invest JPY 400–500 billion in equipment and JPY 250 billion in R&D over the next three years. For a value investor, this means Toray can make money, but to maintain and expand this money-making machine it must keep committing real cash. It is not the kind of light-asset model that naturally spits out abundant free cash with only a little time.

On accounting quality, I did not see obvious signs of fraud or extremely aggressive accounting in public materials. On the contrary, large impairments, asset disposals, and business restructurings are disclosed fairly fully, which looks more like an industrial group acknowledging reality than a company hiding problems behind accounting. But one caution to keep: the company's commonly used "business profit" measure strips out certain non-recurring items, so any analysis must look at operating profit, cash flow, and impairments together, or it is easy to overstate the true resilience of earnings.

Owner Earnings Analysis

Viewed through a more "business-owner" lens, the most important question about Toray is not how good reported FCF looks, but how much genuinely sustainable, distributable cash there is. FY2026 net income attributable to owners was JPY 79.521 billion, depreciation and amortization JPY 131.615 billion, and operating cash flow JPY 211.763 billion; at the same time, the investing-activities cash flow included JPY 80.358 billion of proceeds from disposals and redemptions of investments, while capex expenditure was JPY 146.501 billion. In other words, reported FCF is not equal to free cash generated purely from operations.

My conservative estimate is: maintenance capex roughly equals current-period depreciation and amortization. This is not because I am certain growth investment is zero, but because Toray is a capital-intensive manufacturer where depreciation and capex are highly close, and management again explicitly plans to keep investing large amounts in equipment and R&D. In that case, simply setting maintenance capex "clearly below depreciation" would be too optimistic. On that basis, FY2026 conservative owner earnings is about: operating cash flow JPY 211.763 billion − maintenance capex JPY 134.8 billion ≈ around JPY 77 billion.

This result is crucial, because it tells two things. First, Toray's true distributable cash flow is not as abundant as a "reported FCF of JPY 144.8 billion" makes it look; second, on a conservative owner-earnings basis, the equity value implied by the current share price is about 22x owner earnings, which is not cheap for a materials company with only mid-single-digit ROIC, a complex group structure, and continued cyclical exposure. Put differently, Toray is a textbook case of "looks cheap on P/B, but the OE multiple is not cheap."

Looking further, a meaningful portion of Toray's "free-cash-flow improvement" over the past two years came from disposals of strategic shareholdings and other investments. FY2025 proceeds from disposals and redemptions of investments were JPY 113.747 billion, and FY2026 also had JPY 80.358 billion. Mixing these one-off cash sources with operational generation makes the company look easier than it is. My judgment, therefore, is: profits are real and cash genuinely arrives, but "recurring distributable cash" is below the headline FCF. That is exactly what a long-term owner must guard against.

Valuation, Margin of Safety, and Comparison of Opportunities

Intrinsic-Value Estimate

Owner-Earnings Discount Method

Below are three scenarios. All start from FY2026 conservative owner earnings, with core inputs being starting owner earnings, the next-ten-year growth rate, the discount rate, and the terminal growth rate. Because Toray is a cyclical manufacturer, I deliberately avoided aggressive parameters.

The factual basis underlying these valuations is FY2026 operating cash flow, depreciation and amortization, the capital structure, the share-count reduction, and the company's 2028 business ROIC and profit-improvement targets.

My conclusion is: Conservative intrinsic-value range: JPY 800–950 Fair intrinsic-value range: JPY 1,050–1,300 Optimistic intrinsic-value range: JPY 1,450–1,650

At about JPY 1,160 intraday on 2026-06-03, the current price is at a premium to conservative value, roughly fair against neutral value, and still at a discount to optimistic value. In other words, buying Toray today is essentially a bet that "ROIC improvement will keep being delivered," not picking up an unarguable cigar butt.

Relative-Valuation Method

On a rough look at peer metrics verifiable on public markets as of 2026-06-03, Toray is not conspicuously cheap today:

Note: this is a rough comparison on current multiples directly verifiable from the market. Because the segment structures and accounting conventions of these companies differ greatly, EV/EBITDA and P/FCF can produce false conclusions without same-basis database adjustments, so I only use Toray's own EV/EBITDA of about 10x as a reference and do not force out low-credibility peer values.

The most important message of this table is not that "Toray is very expensive," but that Toray is not as inherently cheap as a sub-1x P/B would suggest. By comparison, Kuraray, as a more focused materials company, currently has lower P/E and P/B; Asahi Kasei offers higher current ROE at a higher P/B. For a value investor, this means Toray's "cheap valuation" is not a sure thing, but strongly depends on your confidence in the self-help improvement.

Asset-Value or Liquidation-Value Method

Toray's FY2026 net assets attributable to owners per share is about JPY 1,236.45, and the current share price is about 0.94x that, which provides some asset anchor. But I would stress three points. First, a materials company's assets include large amounts of dedicated production lines, plants, and process equipment, and liquidation value is usually not equal to book value. Second, the company has already taken large impairments on carbon-fiber and battery-separator assets over the past two years, showing that the book is not impregnable. Third, on a parent-company basis, FY2025 investment securities fell from about JPY 211.278 billion to JPY 98.318 billion, and strategic shareholdings are being continuously disposed of, so the "hidden value of financial assets" has already shrunk versus the past.

So on an asset basis I would rather view Toray as: original book value of about JPY 1,236 per share, but the more credible asset-protection band lies in the JPY 1,000–1,200 per share range. This is a cushion, not a hard floor. It can lower the extreme go-to-zero risk, but it is not enough on its own to constitute a reason to "buy right now."

Price-Range Judgment

Based on the three methods above, I offer the following price framework:

• Ideal buy-price range: JPY 850–950

• Acceptable holding-price range: JPY 950–1,250

• Clearly overvalued range: above JPY 1,450

I require Toray to have at least a 25%–30% margin of safety before I would be willing to upgrade it from "Watch" to "Cautious Buy." The reason is not a poor balance sheet, but that the group is complex, returns are still low, and cash-flow quality needs stricter scrutiny. The current price sits in the middle of "holdable/watchable," not in the "tempting buy zone."

Margin of Safety and Other Opportunities

My core judgment on Toray's current price is: there is value, but the margin of safety is insufficient. The most fragile valuation assumption is that "the company can truly deliver the 2028-target ROIC improvement and convert the advantages of some high-quality businesses into higher owner earnings for the whole group." If growth falls short of expectations and margins merely hover around 4%–5%, the annualized return from buying at the current price may well land only in the low-to-mid single digits.

Compared with the risk-free rate, the current Japanese 10-year government-bond yield is about 2.59%; on my conservatively estimated owner-earnings basis, Toray's current equity yield is about 4.5%. That means the extra compensation you receive is only about 190bp, while you take on single-stock execution, cycle, impairment, and management risk. That risk premium is not generous.

Compared with other opportunities: If you are making a relative allocation within Japanese materials stocks, I think Kuraray is at least a substitute worth a serious comparison, because it is more focused and its current P/E and P/B are no higher than Toray's. If you are comparing against a broad-based index, my view is: Toray currently has no clear certainty advantage over a low-cost broad-based index. You must have a definite edge in your read of Toray's capital-allocation improvement and portfolio optimization for it to be worth the opportunity cost of beating the index. If I could hold only five assets, my answer is: it does not currently qualify for the core portfolio. It is more like "a potential self-help value stock on the watch list" than an excellent company you can hold heavily for the long run without high precision.

Risks, the Bear Case, and Checklists

The Most Important Risks and the Strongest Bear Case

The most important risk is not "share-price volatility," but the following facts that could cause permanent loss of capital:

Note: most of the risks above come from the company's risk disclosures, impairment notes, and cash-flow structure.

I would frame the strongest bear case this way: Toray is neither a cheap bad company nor a cheap good company; it is a complex materials group with good assets but ordinary overall returns over the long run. The market's long-running refusal to award it a high valuation is not entirely a misjudgment, but reflects the lack of a unified, sustained, replicable high-return model across the whole group. A sub-1x P/B easily attracts value investors, but if the next three years still show 4%–5% ROIC, cash flow reliant on asset disposals, and cyclical businesses masking the quality ones, then shareholders may receive only ordinary returns, and may even bear a permanent loss of 30%–40% when the valuation falls back.

What facts, once they appear, should make me admit I was wrong? My standards are:

• By around 2028, group ROIC still sits around 5% over the long run, with no clear move toward a higher level.

• The businesses that "should improve," namely water-treatment membranes, electronic and information materials, and aerospace and high-pressure-vessel carbon fiber, do not deliver into clearly higher profits.

• Reported FCF continues to depend heavily on asset disposals, while operating cash flow minus capex stays persistently weak.

• Large, non-incidental impairments recur, especially concentrated in areas the company defines as growth or priority investments.

• After strategic-shareholding disposals and buybacks end, per-share value improvement clearly slows.

• Debt metrics deteriorate to net debt/EBITDA significantly above the current level.

These are all signals that would trigger me to reassess, even to sell.

Investment Checklist

Note: the conclusions in this checklist integrate the preceding operating, financial, valuation, and risk analysis.

Final Investment Conclusion

Final Rating

Watch

One-Sentence Investment Thesis

Toray is not a bad company, but at the current price it looks more like a complex cyclical materials stock with improving capital allocation than a high-quality compounder with a meaningful margin of safety.

Core Bull Case

• The company owns a set of genuinely high-quality segment assets, especially water-treatment membranes, parts of electronic and information materials, and high-reliability carbon fiber.

• Capital allocation has clearly improved: cutting strategic shareholdings, executing buybacks and cancellations, and setting a DOE target, all of which favor per-share value.

• The balance sheet is broadly tolerable, operating cash flow is consistently positive, and survival ability is not poor.

• The current share price is below book net assets, so extreme-overvaluation risk is no greater than for a high-growth stock.

• Management has put ROIC improvement and portfolio optimization at the core, and the direction is right.

Core Bear Case

• Group-level ROIC/ROE remains low and has not yet proven itself a "good business."

• True distributable cash flow is clearly weaker than the headline FCF, and FCF over the past two years has been substantially supported by asset disposals.

• The business is too complex, and quality assets are diluted by mature or low-return ones.

• Large impairments on carbon fiber and battery separators in recent years show the quality of growth investment is not flawless.

• The current valuation does not form a clear discount versus more focused comparable companies.

Key Assumptions

• High-value-added businesses such as water treatment, electronic materials, and aerospace and high-pressure-vessel carbon fiber continue to expand their profit contribution.

• Capital-allocation improvement is not a one-off but a sustained, institutionalized behavior.

• No frequent large impairments on growth projects recur over the next three years.

• Asset disposals during the period do not become the main source of sustaining shareholder returns.

• Management can deliver part of the 2028 segment ROIC-improvement targets through to the group level.

These are the conditions that must hold for the investment to stand.

Fair Buy Price

JPY 850–950

The basis is: with complexity, cyclicality, capital intensity, and execution risk all present, I want at least a 25%–30% discount to neutral intrinsic value before I would be willing to move it from the watch list to a buyable position. The current price of about JPY 1,160 does not meet this condition.

Target Holding Period

If the price falls into the ideal range in the future and operating improvement keeps verifying, I think it is suitable for holding 5–10 years or more; but at the current price, it is better to watch for 1–2 years first to see whether ROIC, owner earnings, and portfolio improvement are truly delivered.

Expected Annualized Return

Below is my rough pre-tax, dividend-inclusive annualized-return range, an estimate rather than a guarantee:

• Conservative scenario: 2%–4%

• Neutral scenario: 6%–8%

• Optimistic scenario: 9%–11%

I do not give anything higher because the current price is not a deep-undervaluation price, and the spread between the company's true owner-earnings yield and the risk-free rate is not wide. The relevant inputs come from the current share price, conservative owner earnings, the debt structure, and the mid-term improvement targets.

Maximum Loss Risk

I think a 35%–50% permanent loss of capital is not impossible in the worst case. The scenario is usually not corporate failure, but: ROIC failing to rise over the long run, growth businesses taking impairments again, per-share value improvement stopping after asset disposals, and the market re-treating it as a low-quality cyclical materials stock, with valuation falling back to a lower P/B and a lower earnings multiple.

Tracking Metrics

In the future I will focus on these metrics:

• Whether group ROIC and ROE keep rising

• True free cash flow after operating cash flow minus capex

• Owner earnings on a conservative basis

• Water-treatment business revenue, profit, and ROIC

• Profit improvement in electronic and information materials and functional films

• Carbon-fiber segment margins and impairment situation

• Whether large impairments recur

• Net debt/EBITDA and interest coverage

• Strategic-shareholding balance and buyback execution

• Changes in share count and the quality of per-share-metric improvement

These metrics matter more than watching the short-term share price.

Signals That Trigger a Reassessment

• By around 2028, group ROIC is still close to 5% with no clear improvement

• Water treatment and electronic materials fail to become larger profit pillars

• Reported FCF continues to rely on asset disposals for support

• Large growth-business impairments on the order of tens of billions of yen recur

• Capital allocation reverts from "selling low-efficiency assets and cancelling shares via buybacks" back to low-efficiency expansion

• Net debt rises clearly while profit fails to improve in step

If any one of these occurs, it warrants markedly heightened vigilance; if two or three occur at once, the entire investment logic should be re-examined.

Final Recommendation

If you are a balanced-to-conservative investor with a holding period of 10 years or more, my recommendation on Toray is: watch for now, no rush to buy. Its strengths are many, especially its technology assets, global manufacturing capability, and the capital-allocation improvement of the past two years; but its problems are equally clear: low returns at the group level, true distributable cash that looks worse than the reported FCF, a complex business structure, and the delivery of several growth segments that still needs time. I would be willing to upgrade the rating under either of two conditions: either the price falls markedly into a range with a more adequate margin of safety, or, over the next 1–2 years, operating facts prove that ROIC and owner earnings are genuinely rising on a sustained basis. Until then, putting it on the watch list, rather than into a heavy-position list, better fits the principles of long-termism and conservative capital allocation.

This report is based on public information and does not constitute investment advice. Markets carry risk; invest with caution.